Stock Analysis

Hogy MedicalLtd Full Year 2024 Earnings: Misses Expectations

TSE:3593

Hogy MedicalLtd (TSE:3593) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥39.1b (flat on FY 2023).
  • Net income: JP¥2.80b (down 35% from FY 2023).
  • Profit margin: 7.2% (down from 11% in FY 2023).
  • EPS: JP¥116 (down from JP¥178 in FY 2023).
TSE:3593 Earnings and Revenue Growth June 25th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hogy MedicalLtd Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 11%.

Looking ahead, revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Japan.

Performance of the Japanese Medical Equipment industry.

The company's shares are up 1.1% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Hogy MedicalLtd, and understanding them should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Hogy MedicalLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.